Clinical Trials Directory

Trials / Completed

CompletedNCT02861963

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients

Femoral Allogenic Vein Valved Conduit for Palliative Repair of Pulmonary Atresia With Ventricular Septal Defect

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
1 Day – 1 Year
Healthy volunteers
Not accepted

Summary

The aim is to compare effective growth true hypoplastic pulmonary arteries using Right Ventricle Outflow Tract Reconstruction by femoral allogenic vein valve conduit and systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)

Detailed description

The use of femoral allogenic vein valve conduit for Right Ventricle Outflow Tract Reconstruction is good alternative systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt). Main advantages is straight, symmetrical, pulsating, systolic blood flow in hypoplastic pulmonary artery, which stimulate growth and prepares for a radical repair. Taking into account the absence randomized studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual.

Conditions

Interventions

TypeNameDescription
PROCEDUREExperimental: RVOT reconstruction by femoral allogenic vein valve conduitRight ventricular outflow tract reconstruction using femoral allogenic vein valve conduit under CPB and induced ventricular fibrillation
PROCEDURESystemic-to-pulmonary artery shuntsModified Blalock-Taussig shunt performed between the right subclavian and pulmonary arteries or the left subclavian and pulmonary arteries of the type "end to side".

Timeline

Start date
2016-05-05
Primary completion
2019-03-18
Completion
2019-11-22
First posted
2016-08-10
Last updated
2020-06-30

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT02861963. Inclusion in this directory is not an endorsement.

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients (NCT02861963) · Clinical Trials Directory